Sutter Health extends remote heart failure surveillance beyond the clinic
Sutter Health is broadening its digital chronic disease program, Sutter Sync, to include patients with heart failure, adding BodyPort’s FDA-cleared Cardiac Scale to the workflow. The move places daily physiologic monitoring at the center of outpatient management for a condition that can worsen quickly between office visits, often before a patient reaches the emergency department.
For heart failure care, the appeal is straightforward: fluid retention and subtle cardiovascular changes often appear before the dramatic symptoms that send patients to the hospital. A scale that captures those shifts every day gives care teams a running view of risk rather than a static snapshot taken weeks or months apart. In practice, that can mean earlier medication changes, faster outreach, and fewer missed warning signs.
Daily weight data now meets EHR-linked care coordination
BodyPort’s device is designed for simplicity. Patients step on it once a day, much like a standard bathroom scale, while the system measures fluid status and other cardiovascular indicators. The data then flows into Epic, allowing clinicians to review trends in the same record they use for the rest of the patient’s care.
This integration matters because heart failure is rarely managed in a vacuum. When weight trends, symptoms, medication adherence, and prior admissions sit in different systems, the chance of acting on a small but meaningful change drops. Pulling the data into the electronic health record reduces that fragmentation and gives pharmacists and physicians a shared view of the trajectory.
Between visits, Sutter pharmacists monitor the trends and coordinate timely medication adjustments. That kind of pharmacist-led surveillance fits the physiology of heart failure, where diuretics and other therapies often need careful titration to balance congestion against kidney function, blood pressure, and tolerability. A delayed adjustment can mean worsening dyspnea, edema, and avoidable decompensation.
Why remote monitoring is gaining traction in heart failure
Heart failure affects an estimated 7.7 million adults in the U.S., and the disease remains chronic, progressive, and highly variable from day to day. Patients may feel relatively stable one week and show cough, swelling, or shortness of breath the next. Those fluctuations are exactly what make remote monitoring attractive to health systems trying to identify deterioration in a low-acuity setting.
One sentence captures the operational risk: deterioration often starts quietly.
Sutter Health framed the expansion around that clinical gap. Richard Milani, the system’s vice president and chief clinical innovation officer, said regular monitoring between visits helps care teams identify concerning changes earlier and adjust treatment before the condition deteriorates. He also described heart failure as one of the leading causes of hospitalization in the U.S., a reality that keeps systems focused on interventions that might avert acute care use.
The biological logic is sound. In heart failure, fluid overload can accumulate before symptoms become severe enough to prompt a patient to call for help. Daily measurements can surface that upward drift early, when a diuretic adjustment or other intervention may be enough to restore stability. Once congestion progresses, care becomes more complex and the path to hospitalization shorter.
Sutter Sync is expanding from blood pressure into broader chronic disease care
Sutter Sync launched in March 2025 and first opened to patients with hypertension. It later expanded to include patients with high cholesterol in October 2025, and the following April the program began piloting diabetes support. Sutter said more than 13,000 patients have enrolled, and the system claimed that more than 90% of participants with previously uncontrolled blood pressure achieved better control within six months.
Those earlier results help explain the confidence behind the heart failure expansion. Hypertension, dyslipidemia, diabetes, and heart failure often travel together, and the same patient may need repeated education, medication changes, and follow-up across multiple risk states. A digital platform that can move with the patient across diagnoses is operationally efficient and clinically appealing.
The program was built to address three persistent problems in chronic disease management: limited information between office visits, gaps in adherence to evidence-based guidelines, and the challenge of supporting sustained behavior change. Those barriers are familiar in heart failure, where sodium intake, daily self-monitoring, medication adherence, and prompt response to weight gain all influence outcomes but are difficult to sustain over time.
Competitive pressure is rising across the remote monitoring market
Sutter Sync is entering a crowded remote patient monitoring market that already includes companies such as Zoll and Boston Scientific, both of which offer heart failure monitoring tools with EHR integration. The field is moving toward systems that do more than capture data; they must also present it in a way clinicians can act on quickly.
The difference between passive data collection and active care coordination is where many RPM programs succeed or stall. A scale, a sensor, or a diagnostic alert carries value only if someone reviews the signal, recognizes the pattern, and responds before the patient crosses into decompensation. Sutter’s model leans heavily on that second step by tying monitoring to pharmacist review and medication adjustment.
Milani said estimating hospital avoidance would be difficult. He added that Sutter expects a more robust holistic approach with daily monitoring and timely intervention to improve both short- and long-term outcomes for patients with heart failure. That restraint is important. Remote monitoring programs often promise reduced admissions, but the size of that effect depends on patient selection, adherence, workflow design, and whether alerts translate into timely treatment changes.
Heart failure care will depend on whether the alerts change management
The expansion to heart failure turns Sutter Sync into a more layered chronic disease platform, but the practical test is not the technology itself. It is whether daily readings reliably change care before symptoms become severe enough for urgent evaluation.
If the scale detects fluid accumulation early and pharmacists can intervene quickly, the program could reduce the clinical drift that often precedes hospitalization. If alerts are frequent but nonspecific, the burden shifts back onto clinicians and patients. That balance will determine whether the model becomes a durable part of heart failure care or another digital layer added on top of already complex workflows.
For now, the expansion shows how health systems are trying to move heart failure management upstream, into the period when congestion is detectable but still reversible. The next challenge is proving that the extra visibility produces meaningful action at the bedside, not just more data on a screen.